Hovione, the leader in spray drying and particle engineering, announced today an exclusive license agreement for a preclinical ophthalmology program, JX08, with Ji Xing Pharmaceuticals Limited (JIXING).
Leading portfolio executives are sharing perspectives on risk measurement, data integrity and governance, and maximizing R&D budget for new discoveries.
Hovione is present at the 2nd Annual Pharmaceutical Portfolio Strategy & Management Conference in Philadelphia with a participation in a panel discussion.
Panel Title: Developing Agility in the Fast-paced Pharmaceutical Industry
Speaker: Steven Krivicich, Program & Portfolio Director at Hovione
Topics in discussion
- Perspectives on current industry challenges
- Maximizing internal capability for adjustment
- Applying insights to move forward as an industry
If you are attending this conference and would like to chat with us about your projects, schedule a meeting with us. Our colleagues will be pleased to meet you.